FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2112644144> ?p ?o ?g. }

• W2112644144 endingPage "88" @default.
• W2112644144 startingPage "88" @default.
• W2112644144 abstract "Substantial progress has been made in cancer diagnosis and treatment, resulting in a steady improvement in cancer survival. The degree of improvement by age, race, and sex remains unclear.To quantify the degree of survival improvement over time by age, race, and sex in the United States.Longitudinal analyses of cancer follow-up data from 1990 to 2010, from 1.02 million patients who had been diagnosed as having cancer of the colon or rectum, breast, prostate, lung, liver, pancreas, or ovary from 1990 to 2009 and who were included in 1 of 9 population-based registries of the National Cancer Institute Surveillance, Epidemiology, and End Results (SEER) program.Hazard ratios (HRs) and 95% CIs for cancer-specific death were estimated for patients diagnosed as having any of these cancers during 1995 to 1999, 2000 to 2004, and 2005 to 2009, compared with those diagnosed in 1990 to 1994.Significant improvements in survival were found for cancers of the colon or rectum, breast, prostate, lung, and liver. Improvements were more pronounced for younger patients. For patients aged 50 to 64 years and diagnosed from 2005 to 2009, adjusted HRs (95% CIs) were 0.57 (95% CI, 0.55-0.60), 0.48 (95% CI, 0.45-0.51), 0.61 (95% CI, 0.57-0.69), and 0.32 (95% CI, 0.30-0.36), for cancer of the colon or rectum, breast, liver, and prostate, respectively, compared with the same age groups of patients diagnosed during 1990 to 1994. However, the corresponding HRs (95% CIs) for elderly patients (those 75-85 years old) were only 0.88 (95% CI, 0.84-0.92), 0.88 (95% CI, 0.82-0.95), 0.76 (95% CI, 0.69-0.84), and 0.65 (95% CI, 0.61-0.70), for the same 4 cancer sites, respectively. A similar, although weaker, age-related period effect was observed for lung and pancreatic cancers. The adjusted HRs (95% CIs) for lung cancer were 0.75 (95% CI, 0.73-0.77) and 0.84 (95% CI, 0.81-0.86), respectively, for patients aged 50 to 64 years and 75 to 85 years diagnosed between 2005 and 2009, compared with the same age groups of patients diagnosed between 1990 and 1994 (0.73 [95% CI, 0.69-0.77] and 0.90 [95% CI, 0.85-0.95], respectively. Compared with whites or Asians, African Americans experienced greater improvement in prostate cancer survival. From 1990 to 2009, ovarian cancer survival declined among African Americans but improved among whites. No apparent sex difference in the degree of improvement for any non-sex-specific cancer was noted.Younger patients experienced greater benefit from recent oncology advances than elderly patients. African Americans experienced poorer survival than whites for all cancers, and the racial difference decreased for prostate cancer but increased for ovarian cancer. Identifying factors associated with varied improvement in cancer survival can inform future improvements in cancer care for all." @default.
• W2112644144 created "2016-06-24" @default.
• W2112644144 creator A5042491541 @default.
• W2112644144 creator A5045077450 @default.
• W2112644144 creator A5052267876 @default.
• W2112644144 creator A5062616992 @default.
• W2112644144 creator A5070812529 @default.
• W2112644144 creator A5086118402 @default.
• W2112644144 date "2015-04-01" @default.
• W2112644144 modified "2023-10-06" @default.
• W2112644144 title "Disparities by Race, Age, and Sex in the Improvement of Survival for Major Cancers" @default.
• W2112644144 cites W1565276921 @default.
• W2112644144 cites W1967185767 @default.
• W2112644144 cites W1974289641 @default.
• W2112644144 cites W1989421209 @default.
• W2112644144 cites W1997457228 @default.
• W2112644144 cites W2005636762 @default.
• W2112644144 cites W2009443603 @default.
• W2112644144 cites W2022573759 @default.
• W2112644144 cites W2022671313 @default.
• W2112644144 cites W2025383700 @default.
• W2112644144 cites W2027724481 @default.
• W2112644144 cites W2036884664 @default.
• W2112644144 cites W2050942680 @default.
• W2112644144 cites W2064694612 @default.
• W2112644144 cites W2064979057 @default.
• W2112644144 cites W2069443482 @default.
• W2112644144 cites W2074048861 @default.
• W2112644144 cites W2093695090 @default.
• W2112644144 cites W2098223916 @default.
• W2112644144 cites W2098895604 @default.
• W2112644144 cites W2100784844 @default.
• W2112644144 cites W2106787323 @default.
• W2112644144 cites W2109569348 @default.
• W2112644144 cites W2110675408 @default.
• W2112644144 cites W2117342309 @default.
• W2112644144 cites W2118961573 @default.
• W2112644144 cites W2121708973 @default.
• W2112644144 cites W2126856198 @default.
• W2112644144 cites W2129594345 @default.
• W2112644144 cites W2139255330 @default.
• W2112644144 cites W2140375432 @default.
• W2112644144 cites W2146822966 @default.
• W2112644144 cites W2147297736 @default.
• W2112644144 cites W2151595445 @default.
• W2112644144 cites W2154131697 @default.
• W2112644144 cites W2154407182 @default.
• W2112644144 cites W2156492915 @default.
• W2112644144 cites W2157557999 @default.
• W2112644144 cites W2157805580 @default.
• W2112644144 cites W2159146155 @default.
• W2112644144 cites W2161817637 @default.
• W2112644144 cites W2161837929 @default.
• W2112644144 cites W2163059845 @default.
• W2112644144 cites W2166261585 @default.
• W2112644144 cites W2169902698 @default.
• W2112644144 cites W2169961966 @default.
• W2112644144 cites W2219978888 @default.
• W2112644144 cites W2245476761 @default.
• W2112644144 cites W2318977732 @default.
• W2112644144 cites W2917216229 @default.
• W2112644144 cites W4245403358 @default.
• W2112644144 doi "https://doi.org/10.1001/jamaoncol.2014.161" @default.
• W2112644144 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4523124" @default.
• W2112644144 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26182310" @default.
• W2112644144 hasPublicationYear "2015" @default.
• W2112644144 type Work @default.
• W2112644144 sameAs 2112644144 @default.
• W2112644144 citedByCount "265" @default.
• W2112644144 countsByYear W21126441442015 @default.
• W2112644144 countsByYear W21126441442016 @default.
• W2112644144 countsByYear W21126441442017 @default.
• W2112644144 countsByYear W21126441442018 @default.
• W2112644144 countsByYear W21126441442019 @default.
• W2112644144 countsByYear W21126441442020 @default.
• W2112644144 countsByYear W21126441442021 @default.
• W2112644144 countsByYear W21126441442022 @default.
• W2112644144 countsByYear W21126441442023 @default.
• W2112644144 crossrefType "journal-article" @default.
• W2112644144 hasAuthorship W2112644144A5042491541 @default.
• W2112644144 hasAuthorship W2112644144A5045077450 @default.
• W2112644144 hasAuthorship W2112644144A5052267876 @default.
• W2112644144 hasAuthorship W2112644144A5062616992 @default.
• W2112644144 hasAuthorship W2112644144A5070812529 @default.
• W2112644144 hasAuthorship W2112644144A5086118402 @default.
• W2112644144 hasBestOaLocation W21126441442 @default.
• W2112644144 hasConcept C107130276 @default.
• W2112644144 hasConcept C121608353 @default.
• W2112644144 hasConcept C126322002 @default.
• W2112644144 hasConcept C143998085 @default.
• W2112644144 hasConcept C207103383 @default.
• W2112644144 hasConcept C2776235491 @default.
• W2112644144 hasConcept C2778527826 @default.
• W2112644144 hasConcept C2779391198 @default.
• W2112644144 hasConcept C2780192828 @default.
• W2112644144 hasConcept C2781074409 @default.
• W2112644144 hasConcept C2908647359 @default.
• W2112644144 hasConcept C29456083 @default.

• next